MedTrace Logo

Prostatic Arterial Embolization With SQUID (Ethylene Vinyl Alcohol Copolymer )

NCT05395299 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2025-02-24

No results posted yet for this study

Summary

The aim of this pilot study is to analyze the feasibility of prostatic embolization for the treatment of symptomatic benign prostatic hypertrophy with a non adhesive liquid embolic agent (Squid)

Conditions

  • Prostatic Hyperplasia, Benign

Interventions

PROCEDURE

SQUID (Ethylene Vinyl Alcohol Copolymer ) administred to the participant with the intervention Prostatic Arterial Embolization

Prostatic Arterial Embolization with SQUID (Ethylene Vinyl Alcohol Copolymer )

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nice

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-22
Primary Completion
2023-11-22
Completion
2024-10-05

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05395299 on ClinicalTrials.gov